Data from hospitals on medication use are valuable for assessing clinical practice, including undesirable variation, work on therapeutic guidelines and hospital economics. Figures on the use of ...

Bayer meanwhile recently started a fourth phase 3 trial of elinzanetant that will test the drug's ability to treat VMS associated with endocrine therapy of breast cancer.